Address	8840 Wilshire Boulevard Beverly Hills California 90211 United States
Employees	-
Website	http://www.capricor.com
Updated	07/08/2019
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.